Such ICI resistance was described to rely on epigenomic changes on cancer cells, the expression of various ISGs (i.e., Tnfrsf14, Lgals9, MhcII, Ifit, Mx1), and induction of multiple T cell inhibitory receptor networks [227]. Here, MX1 is linked to cancer.